UF cardiologist named one of “World’s Most Influential Scientific Minds”
A University of Florida cardiologist and researcher in Jacksonville was named to Thomson Reuters’ 2014 list of The World’s Most Influential Scientific Minds.
Dominick Angiolillo, MD, PhD, an associate professor of medicine and medical director of cardiovascular research at the UF College of Medicine – Jacksonville, was among 3,200 researchers from around the globe recognized for publishing the highest number of articles most frequently cited by fellow researchers.
In the report, Thomson Reuters said those recognized on the list are considered to be the people of greatest influence in their respective fields, “performing and publishing work that their peers recognize as vital to the advancement of their science.”
Analysts from Thomson Reuters identified most-cited researchers based on papers produced over an 11-year period, from 2002-2012, across 21 broad fields of academic study, including agriculture, computer science, economics, engineering and mathematics. They tracked authors who published numerous articles that ranked among the top 1 percent of the most cited in their respective fields in the given year of publication. These documents represent research that the scientific community has judged to be the most significant and useful.
“Science and innovation are strong drivers of the future – and these people are making that future come to life,” said Basil Moftah, president of Thomson Reuters IP & Science. “The global nature of the study highlights the countries, institutions and researchers on the cutting edge of science. It’s our mission at Thomson Reuters to support these individuals as they advance innovation globally.”
Angiolillo’s research has included studies on coronary artery disease and antiplatelet medications, which prevent blood clot formation. In 2013, he received an Outstanding Achievement Award from the European Society of Cardiology for that line of research.
He has furthered his research by investigating a variety of blood-thinning medications in different clinical settings. Among his endeavors, he has studied personalized antiplatelet treatment approaches, which include genetic assessments. His international recognition in the field has helped attract post-doctoral trainees from across the world to work in his research lab.
View Thomson Reuters’ full report at http://sciencewatch.com/sites/sw/files/sw-article/media/worlds-most-influential-scientific-minds-2014.pdf.